Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 10/20 | 0.34 |
| ▸ | PTGES | O14684 | 1/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.31 |
| ▸ | ACACA | Q13085 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15248668 | 0.99 | KDM4E (0.36) | KDM4EATML3MBTL1PTGER4PDK2 | |
| SCHEMBL19061218 | 0.95 | PDK2 (0.34) | KDM4EATML3MBTL1PTGER4PDK2 | |
| SCHEMBL19061212 | 0.95 | PDK2 (0.36) | KDM4EATML3MBTL1PTGER4PDK2 | |
| SCHEMBL19061253 | 0.95 | PDK2 (0.37) | KDM4EATML3MBTL1PTGER4PDK2 | |
| SCHEMBL8736509 | 0.94 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4PDK2 | |
| SCHEMBL8735634 | 0.94 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4PDK2 | |
| SCHEMBL19061247 | 0.94 | PDK2 (0.35) | KDM4EATML3MBTL1PTGER4PDK2 | |
| SCHEMBL8734513 | 0.93 | MEN1 (0.35) | KDM4EATML3MBTL1PTGER4PDK2 | |
| SCHEMBL8736985 | 0.93 | KDM4E (0.36) | KDM4EATML3MBTL1PTGER4PDK2 | |
| SCHEMBL8735748 | 0.92 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9266851-B2 | Fluorene-containing aromatic compound, material for organic electroluminescent element, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-02-23 | — | — | US | disclosed |
| US-9266851-B2 | Fluorene-containing aromatic compound, material for organic electroluminescent element, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-02-23 | — | — | US | disclosed |
| US-20120126217-A1 | FLUORENE-CONTAINING AROMATIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO. LTD. (JP) | 2012-05-24 | — | — | US | disclosed |
| US-20120126217-A1 | FLUORENE-CONTAINING AROMATIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO. LTD. (JP) | 2012-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120126217-A1 | FLUORENE-CONTAINING AROMATIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | NR0B2, AFF2, AFF1 | KDM4E 2744/4885ATM 4148/4885L3MBTL1 3195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.